Dual epigenetic modifiers for cancer therapy
Epigenetic drug discovery is an emerging strategy for the treatment of cancer and other pathologies. Here, we discuss our recent discovery of first-in-class dual reversible inhibitors of the histone methyltransferase activity of G9a/EHMT2 and DNA methyltransferases showing in vivo efficacy in human...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis Group
2017-07-01
|
| Colección: | Molecular & Cellular Oncology |
| Materias: | |
| Acceso en línea: | http://dx.doi.org/10.1080/23723556.2017.1342748 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|